Fierce market competition seen in anti-hypertension drugs.

To meet the winter seasonal market demands for anti-hypertensive market, the total potentiality of which estimated to 250 billion won, most of leading local pharmaceutical companies are trying to introduce better competitive drugs for hypertensive patients.

Hanmi put Univasc on the market last month and Carvelol this month, Daewoong Dynacirc SRO during the first half of this year and Choong...